Table 1 Patient characteristics
| Â | N (%) |
|---|---|
Sex | |
 Female | 66 (52.0) |
 Male | 61 (48.0) |
Age | |
 Median (years) | 54.3 |
 Range (years) | 25.6–79.5 |
WHO performance score | |
 0 | 52 (40.9) |
 1 | 66 (52.0) |
 2 | 9 (7.1) |
Histology | |
 Leiomyosarcoma | 52 (40.9) |
 Liposarcoma | 33 (26.0) |
 Synovial sarcoma | 16 (12.6) |
 Various others | 26 (20.5) |
Best response | |
 Partial response | 8 (6.3) |
 Stable disease | 64 (50.4) |
 Progressive disease | 45 (35.4) |
 Not evaluable | 10 (7.9) |
Hospital | |
 LUMC | 48 (37.8) |
 NKI-AvL | 40 (31.5) |
 EMC | 15 (11.8) |
 RUMC | 12 (9.4) |
 UMCG | 12 (9.4) |